Assistant Professor, Medicine, Perelman School of Medicine
Oncology
Dr. Alexander E. Perl, MD
|
|
Give Review
Doctor Alexander E. Perl, MD is an expert in the field of Oncology. He went to Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai has a rank of 20 in research and a 62 in primary care Dr. Alexander E. Perl is a published doctor as well. He has 23 publications published. The latest was: Allogeneic transplant for FLT3-ITD+ AML: room for improvement. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Allogeneic transplant for FLT3-ITD+ AML: room for improvement.
- FLT3 Inhibitor-Associated Neutrophilic Dermatoses.
- Crenolanib is a selective type I pan-FLT3 inhibitor.
- Receipt of maintenance therapy is most predictive of survival in older Acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
- Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in Acute myeloid leukemia.
- Phase I study of UCN-01 and perifosine in patients with relapsed and refractory Acute leukemias and high-risk myelodysplastic syndrome.
- Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein Phosphorylation in AML Blasts During a Clinical Trial Combining the mTOR Inhibitor Sirolimus and Intensi...
- The common feature of Leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.
- A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory Acute myelogenous leukemia.
- A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 Acute myeloid leukemia.
- Exploiting signal transduction pathways in Acute myelogenous leukemia.
- Diffuse left ventricular myocardial calcification in the setting of sepsis on CT imaging.
- A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.
- Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
- Large B-cell lymphoma masquerading as Acute leukemia.
- Post-transplant outcomes of induction therapy for Myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphala...
- BCR-ABL kinase is dead; long live the CML stem Cell.
- A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
- A robust xenotransplantation model for Acute myeloid leukemia.
- Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming.
- Evidence of myeloid differentiation in non-M3 Acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
- Targeted signal transduction therapies in Myeloid malignancies.
Schools
Mount Sinai School Of Medicine Of New York University
University Ca San Francisco
Johns Hopkins Hospital
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Coagulation Disorders (incl. Hemophilia)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Johns Hopkins University -
UCSF -
Icahn School of Medicine at Mount Sinai
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1801824321 | |
| NPPES Provider LastName | PERL | |
| NPPES Provider FirstName | ALEXANDER | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 20.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801824321 |
| Last Name Of The Provider | PERL |
| First Name Of The Provider | ALEXANDER |
| View All |
Similar Doctors
|
|
Dr. Yu-Ning Wong, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Leighton Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juhi Mittal, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mary B. Daly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Biermann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey G. Rosenstock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracey Evans, MD
This Doctor is OpenDoctor Recommended.
|